EQUITY RESEARCH MEMO

LeMaitre Vascular (LMAT)

Generated 4/27/2026

Executive Summary

Conviction (model self-assessment)75/100

LeMaitre Vascular is a global medical device company dedicated to developing and commercializing innovative solutions for peripheral vascular disease (PVD). Founded by a vascular surgeon, the company holds a strong legacy in valvulotomes and offers a broad portfolio of devices for arterial reconstruction, biologics, and endovascular procedures. With a focus on niche markets and a direct sales force, LeMaitre has consistently delivered revenue growth and profitability, benefiting from the aging population and increasing prevalence of PVD. The company's disciplined R&D strategy and selective acquisitions have bolstered its product offerings, while its strong balance sheet supports continued investment in innovation.

Upcoming Catalysts (preview)

  • TBDFDA clearance of next-generation valvulotome70% success
  • Q2 2026Expansion of sales force into new international markets65% success
  • Q4 2026Positive clinical data for biologic patch product60% success
Locked sections
  • · Pipeline Analysis
  • · Competitive Landscape
  • · Catalyst Calendar (full 12-month)
  • · Bull Case
  • · Bear Case
  • · Counterfactual Scenarios
  • · Valuation Notes
  • · SEC Filing Highlights
  • · Insider Activity
  • · Literature Watch
  • · Patent Landscape
  • · Mechanism Cluster Map
  • · Audio Briefing (5 min)